A U.S. DEPARTMENT OF ENERGY NATIONAL LAB • SAVANNAH RIVER SITE • AIKEN, SC • USA Ascorbic Acid Stability and pH Testing to Support RWM-018 Pilot Scale Wellhead Treatment System Feasibility Determination Holly VerMeulen, Evan Koelker, Sophia Fuentes September 2025 SRNL-STI-2025-00578, Revision 0 This work was prepared under an agreement with and funded by the U.S. Government. Neither the U.S. Government or its employees, nor any of its contractors, subcontractors or their employees, makes any express or implied: 1. warranty or assumes any legal liability for the accuracy, completeness, or for the use or results of such use of any information, product, or process disclosed; or 2. representation that such use or results of such use would not infringe privately owned rights; or 3. endorsement or recommendation of any specifically identified commercial product, process, or service. Any views and opinions of authors expressed in this work do not necessarily state or reflect those of the United States Government, or its contractors, or subcontractors. Printed in the United States of America Prepared for U.S. Department of Energy ii Keywords: ascorbic acid, oxidant, storage, stability Retention: Varies Ascorbic Acid Stability and pH Testing to Support RWM- 018 Pilot Scale Wellhead Treatment System Feasibility Determination Holly VerMeulen Evan Koelker Sophia Fuentes September 2025 Savannah River National Laboratory is operated by Battelle Savannah River Alliance for the U.S. Department of Energy under Contract No. 89303321CEM000080. iii REVIEWS AND APPROVALS iv TABLE OF CONTENTS LIST OF TABLES ................................................................................................................................. vi LIST OF FIGURES ................................................................................................................................ vi LIST OF ABBREVIATIONS ................................................................................................................ vii 1.0 Introduction ....................................................................................................................................... 1 2.0 Objectives.......................................................................................................................................... 1 3.0 Method .............................................................................................................................................. 1 3.1 Part 1: Stability testing ................................................................................................................... 1 3.1.1 Photodegradation Testing......................................................................................................... 2 3.1.2 Thermal Degradation Testing ................................................................................................... 2 3.1.3 Reductant Efficacy Testing ...................................................................................................... 3 3.2 Part 2: Combined Network pH assessment...................................................................................... 3 4.0 Results and Discussion ...................................................................................................................... 5 4.1 Part 1: Stability testing ................................................................................................................... 5 4.1.1 Photodegradation Testing......................................................................................................... 5 4.1.2 Thermal Degradation Testing ................................................................................................... 8 4.2 Part 2: pH assessment................................................................................................................... 12 5.0 Conclusions ..................................................................................................................................... 13 6.0 Recommendations ........................................................................................................................... 14 7.0 References ....................................................................................................................................... 14 8.0 Distribution ..................................................................................................................................... 16 v LIST OF TABLES Table 3-1. Flow Rates for Existing Recovery Well Network Based on 2015-2021 Operating Data. .......... 4 Table 4-1. Measurements Supporting pH Assessment ............................................................................ 13 LIST OF FIGURES Figure 3-1. Ascorbic Acid Sample Storage Container Types - Clear and Opaque HDPE Plastic ............... 2 Figure 4-1. Qualitative (color) change of ascorbic acid solution during storage. Image (a) was taken prior to storage and image (b) was taken after storage for four weeks. ....................................................... 5 Figure 4-2. Incremental Dosing of Ascorbic Acid Solution to 140 mL Sample of 1500 ppm Potassium Permanganate Solution to Determine Minimum Volume Needed for Complete Neutralization .......... 6 Figure 4-3. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Outside Storage in a Clear Container.......................................................................................................................... 7 Figure 4-4. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Outside Storage in an Opaque Container .................................................................................................................... 8 Figure 4-5. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Cold Storage ....................................................................................................................................................... 10 Figure 4-6. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Room Temperature Storage ...................................................................................................................... 11 Figure 4-7. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Hot Storage 11 Figure 4-8. Physical Deformation of Sample Bottle from Hot Storage in Opaque Sample Container....... 12 Figure 4-9. Bubbling Observed in Ascorbic Acid Sample Stored Under Hot Conditions in a) Opaque and b) Clear Containers......................................................................................................................... 12 vi LIST OF ABBREVIATIONS CEDMS Comprehensive Environmental Data Management System CO2 Carbon Dioxide cVOC Chlorinated Volatile Organic Compound DI Deionized DNAPLs Dense Non-Aqueous Phase Liquids gpm Gallons Per Minute HDPE High-Density Polyethylene ISCO In-Situ Chemical Oxidation M Molar NPDES National Pollutant Discharge Elimination System ORP Oxidation Reduction Potential SRNL Savannah River National Laboratory SRS Savannah River Site UV Ultraviolet WAC Waste Acceptance Criteria vii 1.0 Introduction A multitude of groundwater remediation techniques for chlorinated volatile organic compounds (cVOCs) have been conducted at the A/M-Areas of the Savannah River Site (SRS). Historical in-situ chemical oxidation (ISCO) injections of potassium permanganate and sodium persulfate conducted in 2018 and 2020, have left residual oxidant concentrations in the A/M-Area groundwater system. ISCO events targeted dense non-aqueous phase liquids (DNAPLs) through the injection of strong oxidants within plume zones upgradient of current groundwater recovery wells RWM-008 and RWM-018. These residual oxidants could significantly impede the operation of the mercury removal system needed to meet National Pollutant Discharge Elimination System (NPDES) permit requirements for the ongoing pump-and-treat system that hydraulically controls potions of the A/M-Area plume. Effluent treated groundwater from this system is discharged to surface water at the receiving outfall of the M-1 Air Stripper. To prevent interference of the M-1 Air Stripper system by residual oxidants, groundwater recovery has been ceased at well RWM-018. Modeling of oxidant transport in A/M-Area from ISCO estimated that the potential oxidant load contributed by RWM-018 could be as high as 120 mg/L. It is also possible that oxidants may be contributed via pumping at well RWM-008 in the near future as residual oxidants within the aquifer migrate toward its zone of influence. Savannah River National Laboratory (SRNL) has conducted research to investigate potential pre- treatment chemicals to neutralize these residual oxidants, before reaching the M-1 Air Stripper, to allow for resumed groundwater recovery at RWM-018 and continued pumping at RWM-008. Deployment of ascorbic acid for neutralization of residual oxidants at RWM-018 (and possibly RWM-008) is recommended based on results from previous reductant testing (SRNL, 2021). For a maximum estimated oxidant load at RWM-0018, a well-head treatment system would need to dose about 400 gallons of ascorbic acid each month to ensure complete neutralization. A second system with additional reagent should also be considered for deployment at RWM-008. 2.0 Objectives The primary objective of this work was to build upon previously conducted research by investigating the practical field use of ascorbic acid reductant in a pre-treatment system. To do this, SRNL evaluated the stability of 2 molar (M) ascorbic acid solution under various storage conditions, including the possible impacts from photodegradation and temperature changes, to simulate the long-term storage of ascorbic acid solutions in various outdoor conditions. The efficacy of this solution for neutralization of oxidant, after simulated storage conditions, was then tested. Additionally, the impact of reductant introduction on total recovered groundwater pH was also simulated to ensure that this additive treatment would not lower the pH of groundwater entering the M-1 Air Stripper, causing it to fall outside of the defined waste acceptance criteria (WAC). This report contains results from both stability experiments and the pH assessment. 3.0 Method The testing approach was designed to simulate real-world conditions of ascorbic acid reductant storage and its introduction to the groundwater recovery system of the M-1 Air Stripper. Reductant solutions were prepared to concentrations recommended for field use in proposed treatment systems. All testing conducted for pH assessments utilized recovered groundwater from the M-1 Air Stripper system to match field conditions as closely as possible. 3.1 Part 1: Stability testing Stability testing assessed the impact of storage conditions on ascorbic acid stability in solution. Temperature and natural light exposure were varied to isolate variables that could contribute to ascorbic acid reductant degradation, if any. Solutions were exposed continuously to conditions for up to four weeks during testing to determine the efficacy of ascorbic acid reductant solutions as a function of storage time under varied temperature and light exposure conditions. The 2 M ascorbic acid solution used for testing was selected based on previous reductant saturation testing (SRNL, 2021) and represents the maximum concentration of 1 reductant that can be put into solution without precipitation from oversaturation. Utilization of concentrated reductant is necessary to reduce additive volumes and subsequently the equipment and materials needed to deploy the proposed reductant additive system. All reductant solutions consisted of the reducing agent (ascorbic acid), deionized (DI) water, and dilute sulfuric acid. Each acidified reductant solution was comprised of equal volumes of ascorbic acid (in DI water) and 1 M sulfuric acid in DI water. Reductant solutions were acidified with sulfuric acid to allow for the complete reduction of Mn7+ (from permanganate) to Mn2+ and prevent the formation of intermediate manganese oxidation states, such as Mn4+, from forming. 3.1.1 Photodegradation Testing Reductant solutions used in wellhead treatment systems may be exposed to natural light for prolonged periods of time. Degradation of reductant solutions resulting from exposure to ultra-violet (UV) light could possibly occur from prolonged solution storage under these conditions. To determine if light has an impact on solution stability or efficacy after storage, a subset of solutions were exposed to natural UV light. Periodically, these solutions were tested to determine the capability of reductant to neutralize known quantities of oxidant. Aliquots of each solution were stored separately; one in clear plastic (HDPE) to allow for exposure to natural light and one in an opaque plastic (HDPE) container to obscure light (Figure 3-1). Other container materials were not investigated because of their potential incompatibility with the solution (e.g. some metals) or lack of practicality in field systems (e.g. glass). All testing was performed in duplicate. Figure 3-1. Ascorbic Acid Sample Storage Container Types - Clear and Opaque HDPE Plastic All containers were stored outdoors under ambient conditions for approximately 30 days to assess any changes to solution stability and/or efficacy as a result of UV light exposure. During photodegradation testing, each solution from each storage condition was assessed for a) qualitative signs of change (e.g. color change) and b) visual precipitation (if any) semiweekly. Additionally, an aliquot of each solution was removed and used to neutralize a sample of known oxidant concentration once a week to identify any reduction in efficiency resulting from photodegradation. 3.1.2 Thermal Degradation Testing Storage temperature was also varied for each container type to assess its impact on the stability of reductant solutions. Three experiments were performed using a Binder KMF 240 Environmental Chamber to control 2 ambient conditions for each test. Aliquots of ascorbic acid reductant solution were divided and placed into containers. Each experiment consisted of duplicate opaque HDPE containers and clear HDPE containers of ascorbic acid solution. Samples were stored in three ambient conditions: a) at room temperature, b) in a cold environment (~ 40 °F), and c) in a hot environment (~ 90 °F). A constant climate was maintained in each of these experiments for four weeks. The environmental chamber was kept void of light to remove any possible interference from photodegradation. Semiweekly during this study, each solution from each storage condition was assessed for a) qualitative signs of change (e.g. color change) and b) visual precipitation (if any). Once per week, an aliquot of ascorbic acid solution from each storage condition was collected and used to neutralize a sample of known oxidant concentration to identify any change in reductant solution efficacy. A freshly made sample was used to confirm neutralization dosing quantities prior to storage. Results from this trial, prior to any thermal or photodegradation testing, are referred to as ‘baseline’ in testing results. Results from all three temperature trials (cold, hot, and room temperature) were compared to the baseline sample results at the completion of testing. 3.1.3 Reductant Efficacy Testing Once per week, each ascorbic acid reductant solution was tested for any measurable loss in efficacy. Experimentation was performed by dosing an oxidant solution of known concentration with each reductant solution. Concentrations of oxidant were identical between tests. If the volume of reductant needed to reach complete reduction increased over time, it would be concluded that the reductant solutions had been degraded under those storage conditions. The efficacy testing approach is as follows: 1. Small, approximately 5 mL, aliquots of ascorbic acid reductant solution were retrieved from each parent container undergoing either thermal or photodegradation testing each week. These aliquots were obtained individually from each replicate sample following visual inspection. 2. Under constant agitation at 200 rpm, oxidant solutions (1500 ppm potassium permanganate in DI water) were placed into beakers monitored by a YSI water quality meter to measure pH and oxidation-reduction potential (ORP). 3. The pH and ORP measurements of oxidant stock solutions were allowed to stabilize and then recorded before any reductant addition. 4. Measured volumes of ascorbic acid reductant were added to each oxidant stock solution until complete neutralization was achieved. I. Following each addition of ascorbic acid reductant, pH and ORP values were allowed to stabilize and were recorded. II. Notation of any intermediate precipitation or color changes were also recorded following each ascorbic acid reductant addition. 5. Complete neutralization was determined after ORP readings were noted to have reached an asymptote following subsequent additions of ascorbic acid reductant. At the conclusion of each titration, final values of pH, ORP, visual inspections, and total ascorbic acid reductant volumes were recorded. 6. Volumes of ascorbic acid reductant necessary for complete neutralization were then compared to baseline values to determine any potential degradation in reductant efficacy. 3.2 Part 2: Combined Network pH assessment To ensure the pH of M-1 Air Stripper influent is within the WAC-required range of 2 to 12.5 after reductant is introduced, the pH assessment experimentation was designed to estimate the pH of ascorbic acid-treated M-Area groundwater once it reaches the M-1 Air Stripper inlet. Groundwater at the M-1 Air Stripper inlet represents water from multiple individual recovery wells. A batch study was used to simulate dosage at the 3 RWM-018 wellhead and then dilution from other recovery wells in the network, simulating groundwater conditions prior to entering the M-1 Air Stripper inlet for treatment. For the combined network pH assessment, a 140 mL solution of known oxidant concentration was generated to simulate recovered groundwater from well RWM-018. This solution contained 1500 ppm total oxidant (potassium permanganate), which is the highest oxidant concentration previously measured in M-Area wells (SRNL, 2021). This sample was then dosed with 2 M ascorbic acid solution based on recommendations from previous testing (SRNL, 2021). Once treated with the ascorbic acid solution, M-Area groundwater collected from the M-1 Air Stripper inlet was used to dilute the sample by approximately 8.2 times. This dilution factor was determined based on the combined average recovery water flow rate from each operating well in the recovery well network (Table 3-1). The RWM-018 median flow rate when operated was 54.8 gpm, while the total flow from all the recovery wells (based on median flow for each) is 454.8 gpm. Therefore, the averaged total flow rate of the M-1 Air Stripper recovery well network, when operating, was found to be approximately 8.2 times the flow rate of RWM-018. The pH of each solution was measured periodically during this experiment. Measurements of pH were recorded prior to ascorbic acid addition, after the reductant had been added, and then following dilution with M-1 Air Stripper inlet groundwater. For these experiments, it was assumed that the stannous chloride system does not significantly impact the pH of the M-1 Air Stripper influent based on recent monitoring data collected from the Comprehensive Environmental Data Management System (CEDMS) database. Historical measurements show that M-Area groundwater has an average pH of approximately 4-5 prior to treatment (source: CEDMS data for WSM001 and WSM003 clusters 1/1/2022-present) and the pH at the M-1 Air Stripper inlet has varied between 4.5 and 6.9 since 2023. The pH of the M-1 Air Stripper effluent has historically varied between 4.7 to 6.5 since 2023, indicating the stannous chloride additions have minimal impact. This supports the assumption that pH is consistent within this range with the addition of stannous chloride to M-1 Air Stripper influent groundwater. Any measurable deviation from this range during combined network pH assessment would then likely be attributable to the addition of the simulated groundwater from well RWM-018 or the ascorbic acid reductant used to neutralize its oxidant content. Table 3-1. Flow Rates for Existing Recovery Well Network Based on 2015-2021 Operating Data. Existing Recovery Wells Median wastewater flowrate (gpm) (a) RWM 1 9.7 RWM 2 28.9 RWM 3 57.0 RWM 4 47.3 RWM 5 48.2 RWM 6 19.4 RWM 7 34.6 RWM 8 44.6 RWM 9 0.0 RWM 10 42.3 RWM 11 0.0 RWM 17B 0.0 RWM 17D 0.0 RWM 18 54.8 RWM 19 68.3 Sum 454.8 a Monthly flow data reported in 2021 Annual M-Area and Met Lab HWMFs Groundwater Monitoring and Corrective Action Report (SRNS, 2021). 4 4.0 Results and Discussion 4.1 Part 1: Stability testing 4.1.1 Photodegradation Testing Both clear and opaque bottles containing ascorbic acid were stored outside under ambient conditions to assess the potential impact of photodegradation on the efficacy of the solution for oxidant neutralization. Replicates contained in opaque containers were subject to identical conditions as samples contained within clear containers to isolate reductant efficacy variations caused by photodegradation. Each solution from each storage condition was assessed for a) qualitative signs of change and b) visual precipitation (if any). A visual change in ascorbic acid solution color (darkening of yellow color; example shown in Figure 4-1) was observed for all photodegradation samples, but no precipitation was observed in any sample throughout the duration of testing. Figure 4-1. Qualitative (color) change of ascorbic acid solution during storage. Image (a) was taken prior to storage and image (b) was taken after storage for four weeks. These ascorbic acid solutions were also used to neutralize lab-generated oxidant standards containing 1500 ppm potassium permanganate a) immediately following preparation (prior to any storage) and then b) once weekly for four weeks following identical procedures detailed in section 3.1.3. Reaction endpoints of the redox titrations were determined through both color change, as well as continuous ORP (mV) measurement using a YSI probe. Complete neutralization is considered achieved in each sample when ORP values drop rapidly and significantly after reductant addition and then plateau at a reduced value once the reaction is complete. Initial scoping trials were completed to determine the minimum amount of 2 M ascorbic acid needed to neutralize 140 mL of a solution with 1500 ppm potassium permanganate. This was done by slowly adding the higher strength ascorbic acid solution while monitoring ORP until a baseline was established after the initial drop (Figure 4-2). From this test, it was determined that a minimum 2.1 mL volume of reductant solution was needed to completely neutralize the 1500 ppm oxidant solution. This dosing volume was used in all the subsequent neutralization testing completed in this study. 5 1000 800 600 ORP (mV) 400 200 0 0 0.5 1 1.5 2 2.5 3 -200 -400 Figure 4-2. Incremental Dosing of Ascorbic Acid Solution to 140 mL Sample of 1500 ppm Potassium Permanganate Solution to Determine Minimum Volume Needed for Complete Neutralization Figure 4-3 displays these redox titration curves for photodegradation testing conducted in clear containers that were stored outside, i.e., exposed to natural UV light. The ‘baseline’ curve represents results from neutralization of oxidant solution with the 2 M ascorbic acid solution prior to any storage. No noticeable differences in efficacy were observed for the clear bottles as time progressed. For all solution storage durations (1-4 weeks), during ascorbic acid dosing, the initial ORP of the solutions were relatively consistent (between 673.1 and 752.3 mV) and then dropped significantly following reductant addition. Stabilization occurred after the addition of 2.1 mL of solution in all cases. These trends mirror that seen for the ‘baseline’ sample (tested immediately following preparation), supporting that UV light did not result in degradation of the ascorbic acid solutions within four weeks of sample exposure. Though solution color did darken slightly with storage in opaque containers, similar to the solutions in clear containers, replicate samples contained in opaque containers showed no noticeable differences in titration efficacy seen as time progressed for outside storage (Figure 4-4). The trends seen in opaque bottle data mirrors that of the clear bottles stored in the same manner under identical conditions. The lack of significant difference between the clear and opaque bottles under the same conditions supports that UV light exposure does not significantly decrease the efficacy of ascorbic acid reductant following four weeks of exposure. The lack of ascorbic acid degradation in response to UV exposure is likely a function of pH. Under acidic conditions, ascorbic acid is more resistant to photodegradation than under alkaline conditions (Yin et al., 2022). The 2 M reductant solution has a pH of about 4.25 when in solution with sulfuric acid, which likely contributed to its stability under UV-irradiation. Though a decrease in efficacy was not seen as a result of photodegradation from outside storage in clear or opaque containment, gas generation within containers was first noted following one week of testing. An audible release of pressurized gas was noted during opening all containers kept in outdoor conditions; however, no physical deformation to any of the sample bottles was observed. The gas being produced as a result of outside storage of the ascorbic acid and sulfuric acid mixture is likely carbon dioxide (CO2). CO2 is a biproduct from ascorbic acid degradation, which can be accelerated by heat and the acidic environment created from the addition of sulfuric acid (Yin et al., 2022). It is recommended that a well-head treatment 6 system design incorporate a venting mechanism for gas release. Proper venting of the storage tank could be accomplished with automated check valves, for example, to allow pressure to be released and prevent gas buildup. 1000 800 600 400 Average ORP (mV) 200 0 0 0.5 1 1.5 2 2.5 3 3.5 -200 -400 -600 -800 Week one: outside storage, clear bottle Week two: outside storage, clear bottle Week three: outside storage, clear bottle Week four: outside storage, clear bottle baseline Figure 4-3. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Outside Storage in a Clear Container 7 1000 800 600 400 Average ORP (mV) 200 0 0 0.5 1 1.5 2 2.5 3 3.5 -200 -400 -600 -800 Week one: outside storage, opaque bottle Week two: outside storage, opaque bottle Week three: outside storage, opaque bottle Week four: outside storage, opaque bottle baseline Figure 4-4. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Outside Storage in an Opaque Container 4.1.2 Thermal Degradation Testing Ascorbic acid reductant solutions were stored under varying temperature conditions to assess the impact of thermal degradation on efficacy and stability over time. Three tests were conducted using ascorbic acid contained in clear and opaque containers stored in cold (40 °F), room temperature (~ 70 °F), and hot (90 °F) conditions. An environmental chamber was used to maintain both hot and cold environments, and room temperature samples were stored on the lab bench away from windows for the duration of testing. Both clear and opaque bottles were included in this testing for each condition to identify any variability caused by exposure to light. Each solution from each storage condition was assessed for a) qualitative signs of change and b) visual precipitation (if any). A visual change in ascorbic acid solution color (darkening of yellow color) was, again, observed for all samples in this trial, but no precipitation was observed in any sample throughout the duration of testing. No change in efficacy as a result of cold storage was seen over the four-week testing period, regardless of container color (clear vs opaque; Figure 4-5). There was also no change in efficacy seen to occur from room temperature storage (Figure 4-6). Results of these tests are consistent with data found during a literature review of related laboratory studies conducted with ascorbic acid. The concentration of ascorbic acid within a solution has been shown to affect its stability. Lower concentration solutions more readily degrade than those with elevated concentrations, especially in the presence of light (Yin et al., 2022). The lack of efficacy reduction seen in photodegradation and thermal degradation testing (cold and room temperature) results can likely be attributed to the use of high concentration solutions. 8 Ascorbic acid reductant stored under hot conditions, however, show more varied results than those for the cooler temperatures. Results of high temperature condition testing are shown in Figure 4-7. A significant decrease in ORP is still seen to occur with the initial 2.1 mL addition of ascorbic acid stored under hot conditions. However, these results show ORP values that do not reach an asymptotic plateau for either bottle type (clear or opaque) after this initial sharp decrease in contrast to other trials. Instead, the ORP values begin to increase, or rebound, sharply as more ascorbic acid is added. In addition, data collected during neutralizations with the samples stored under high temperature (90 F°) shows that ORP values do not consistently reach the -400 mV range seen in lower temperature trials before rebounding to higher readings. These results indicate that storage at higher temperatures may result in degradation of the reductants and a resulting decrease in efficacy. Ascorbic acid can be degraded by heat. Previous studies have found that a storage temperature below about 25 °C (~ 77 °F) is typically preferable for maintaining the ascorbic acid content of a liquid (Yin et al., 2022). This reductant can be significantly degraded when stored around 90 °F, even when stored in the dark (Yin et al., 2022). Degradation at elevated temperatures above ~90 °F is supported by the reduced efficacy that was observed with the solutions stored under hot conditions in this study. Storage tank temperature regulation should be considered when designing a chemical dosing system to prevent potential loss in reductant efficacy, particularly in summer months. Audible pressure/gas release was also heard when opening all hot-stored bottles. Visible bottle deformation (Figure 4-8) and the occurrence of gas trapped in solution (Figure 4-9) was observed as a result of hot conditions for both bottle types. Significant physical deformation is seen for the opaque bottles stored in hot conditions only, but some mild deformation (rounding of bottle base) was also noted for clear containers. Deformation of opaque containers was observed following two weeks of storage, while the less severe deformation was not noted in the clear containers until week four. The gas produced as a result of heating a mixture of ascorbic acid and sulfuric acid is likely CO2, generated as a biproduct of ascorbic acid degradation in the acidic environment created from the addition of sulfuric acid. Sulfuric acid is not expected to lead to significant gas formation at 90 °F, and it is unlikely that a direct reaction is occurring between ascorbic acid and sulfuric acid that would result in gas generation under these conditions (Yin et al., 2022). Best Practices for a long term ascorbic additive storage and additive system are informed by stability testing results. A chemical additive system is proposed to be located at the RWM-0018 wellhead to continuously inject ascorbic acid reductant into recovered groundwater for oxidant neutralization. Efficient design of such an additive system would likely seek to minimize maintenance and chemical handling while maximizing reliability and efficiency. Best practices for consideration in an additive system design as a result of SRNL testing include: • Thermal protection from temperature extremes o The use of a double lined insulated storage tank to hold ascorbic acid solutions would help with managing temperature increases in the warmer months. Insulation of any transfer lines/connections between the tank and injection point may also be employed to ensure that complete thermal protection is achieved for lines that contain additive beyond a larger reservoir. o Use of a covering or (vented/open) enclosure to keep the tank shaded may also help with reducing maximum temperatures of an additive system enclosure. o Implementation of a climate controlled, weatherproof enclosure could also be used for temperature regulation and should be considered. o Constant mixing or agitation of stored ascorbic acid reductant solutions should also be considered to ensure more consistent temperature distribution throughout a storage vessel. • Storage vessel ventilation o The buildup of CO2 gas within some sample containers during testing could also potentially occur in storage vessels within an additive system. Though temperature regulation may minimize this gas buildup, proper venting of the storage tank through passive or active 9 means should be considered. Simple check valves to allow pressure to be released and prevent gas buildup could be sufficient for this purpose. o Pressure gauges or CO2 monitors external to any additive system enclosure may also be beneficial to monitor any potential gaseous buildup. 1000 baseline 800 Week one: cold storage, clear bottle 600 Week one: cold storage, opaque bottle 400 Average ORP (mV) Week two: cold storage, clear bottle 200 Week two: cold storage, opaque bottle 0 Week three: cold storage, clear bottle 0 1 2 3 -200 Week three: cold storage, opaque bottle Week four: cold storage, clear bottle -400 Week four: cold storage, opaque bottle -600 -800 Figure 4-5. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Cold Storage 10 1000 baseline 800 Week one: room temperature storage, 600 clear bottle Week one: room temperature storage, 400 opaque bottle Average ORP (mV Week two: room temperature storage, 200 clear bottle Week two: room temperature storage, 0 opaque bottle 0 1 2 3 Week three: room temperature -200 storage, clear bottle Week three: room temperature -400 storage, opaque bottle Week four: room temperature storage, -600 clear bottle Week four: room temperature storage, -800 opaque bottle Figure 4-6. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Room Temperature Storage 1000 baseline 800 Week one: hot storage, clear bottle 600 Week one: hot storage, opaque bottle 400 Average ORP (mV Week two: hot storage, clear bottle 200 Week two: hot storage, opaque bottle 0 0 1 2 3 Week three: hot storage, clear bottle -200 Week three: hot storage, opaque -400 bottle Week four: hot storage, clear bottle -600 Week four: hot storage, opaque bottle -800 Figure 4-7. Change in ORP of Reductant Solution in Response to Ascorbic Acid Addition: Hot Storage 11 Figure 4-8. Physical Deformation of Sample Bottle from Hot Storage in Opaque Sample Container Figure 4-9. Bubbling Observed in Ascorbic Acid Sample Stored Under Hot Conditions in a) Opaque and b) Clear Containers 4.2 Part 2: pH assessment To ensure the pH of the M-1 Air Stripper influent is still within the acceptable permit-required range of 2 to 12.5 after addition of ascorbic acid solution, a batch test was executed to estimate the pH of ascorbic acid-treated M-Area groundwater once it reaches the M-1 Air Stripper inlet. Dosage at the RWM-018 wellhead was simulated by neutralizing a sample of high oxidant concentration (1500 ppm potassium permanganate) with the 2 M ascorbic acid solution (based on previous dosing trials). Following neutralization, the sample was diluted with M-Area groundwater to mimic its combination with groundwater from other recovery wells in the network during transit to the M-1 Air Stripper. pH values were recorded at all steps of this batch testing (Table 4-1). This test was performed in duplicate, and good agreement was found between replicates at all stages of testing. 12 Throughout the study, during all replicates, the pH of the solution never fell outside of the permit-required range of 2 to 12.5. The average pH of the sample rose from 5.98 to 8.45 as a result of the chemical reaction taking place during neutralization. The neutralization of potassium permanganate by ascorbic acid in an acidic environment (like M-Area groundwater) generates dehydroascorbic acid from the oxidation of ascorbic acid, while the permanganate ion is reduced (Equation 1; Yin et al., 2022). As a result, the pH increases as the reaction consumes hydrogen ions provided by the sulfuric acid, causing the pH to rise as the reaction proceeds towards completion. 5𝐶6 𝐻8 𝑂6 + 2𝐾𝑀𝑛𝑂4 + 3𝐻2 𝑆𝑂4 → 5𝐶6 𝐻6 𝑂6 + 2𝑀𝑛𝑆𝑂4 + 𝐾2 𝑆𝑂4 + 8𝐻2 𝑂………………….Equation 1 Then after significant (8.2 x) dilution with acidic M-Area groundwater (average pH = 5.18), the final (average) pH of the sample dropped slightly to 8.27. Assessment of pH during simulated reductant dosing and dilution experimentation shows that dosing of the ascorbic acid solution at the recommended rate is not expected to result in a pH change outside of the permit-required limit during normal operation of the groundwater recovery system. It should be noted that pH assessment experimentation was conducted using flow rates for wells currently operating and listed in Table 3-1. The dilution factor of 8.2x is dependent upon the operation of all wells and their flow rates used in this study. Should operation of the groundwater recovery system be altered to discontinue pumping from currently listed wells, while continuing to draw ascorbic acid reductant amended groundwater from recovery wells with operational treatment systems, the dilution factor would change. Regardless, the pH of ascorbic amended groundwater immediately following extraction from well RWM-018 (pH=8.28) shows that it is not possible to exceed the pH limit of 12.5 even if all other recovery wells are shut down. Furthermore, the addition of ascorbic acid reductant treatment systems at other recovery wells would likely have similar results. Groundwater extraction that feeds into the M-1 Air Stripper is recovered from similar depths from the same aquifer unit. Meaning that duplicate treatment schemes from additional wells would also be unlikely to increase the pH of a combined groundwater recovery in excess of a pH of approximately 8.28, well below the limit of 12.5. Table 4-1. Measurements Supporting pH Assessment Average pH Sample description/treatment (standard deviation) M-1 Air Stripper inlet water (no treatment/as collected) 5.18 (0.27) 1500 ppm potassium permanganate solution made with M-1 Air Stripper inlet water 5.98 (0.53) After adding 3 mL of 2 M ascorbic solution to 140 mL of 1500 ppm potassium permanganate to neutralize oxidant 8.45 (0.17) (added under constant agitation and then let pH stabilize before recording) Dilute sample in column above by 8.2 times using additional M-1 Air Stripper inlet water 8.27 (0.37) 5.0 Conclusions Storability and pH testing show that ascorbic acid reductant solutions may be practically employed in field scale treatment systems for the neutralization of residual oxidants without compromising the pH limits of M-1 effluent discharge water. By simulating the conditions of longer term storage of the proposed ascorbic acid reductant solution, under varied conditions representative of outdoor storage, recommendations for best practices and design considerations have been identified to optimize field scale additive system design using ascorbic acid solutions. Several key factors were identified during stability testing that indicate 13 temperature regulation and venting are of primary importance for long term storage of ascorbic acid reductant solutions. The simulation of ascorbic acid amended groundwater from well RWM-018 proves that there is little risk to the overall M-1 Air Stripper groundwater recovery and treatment system by the addition of oxidant pre- treatment systems using this reductant. Previous testing has shown that the use of ascorbic acid to neutralize residual ISCO oxidants is no threat to the efficiency of stannous chloride treatment at the inlet of the M-1 Air Stripper (SRNL, 2024). Further, testing conducted by SRNL to mimic the combination of ascorbic treated groundwater recovered from well RWM-018 into the overall recovery system of the M-1 Air Stripper will not jeopardize effluent fluid quality objectives related to set pH ranges. Using the appropriate additive system design choices and ascorbic acid reductant solution formulations, the treatment of residual oxidant in recovery water from wells RWM-018, and potentially RWM-008, is possible and recommended without threatening the ongoing groundwater recovery system of A/M-Area. SRNL recommends the use of such a treatment system with the objective of resuming groundwater extraction at well RWM-018. 6.0 Recommendations Recommendations based upon observed characteristics of ascorbic acid during storability and pH testing include: • It is recommended that the ascorbic acid reductant containers be shielded or otherwise protected from maximum ambient temperatures during summer months should these solutions be stored for multiple weeks within a treatment system. • It is also recommended to incorporate a venting mechanism into the chemical additive system to prevent possible pressurization of storage tanks or CO2 buildup. • Other recommended design considerations include direct sunlight shielding by canopy or enclosure, double walled or insulated storage vessels for ascorbic solutions, and/or stirring mechanisms to evenly distribute the temperature during storage. • Testing supported that dosing of ascorbic acid at the recommended rates based on maximum expected oxidant concentrations expected in M-Area groundwater did not result in M-1 Air Stripper influent pH exceeding the permitted range, and that maximally concentrated ascorbic solutions (2 M) be used for additive systems. 7.0 References CEMDS database (2025) SGW Remediation Support: Analytical Results II. Woodward and Batson (2012) Method of controlling by-products of vitamin C degradation and improving package integrity shelf life. US Patent number: US20120067431A1. Accessed at: 1498381508673677417- US20120067431A1. SRNL (2021) SRNL-L3200-2021-00109, rev. 0. Residual Oxidant Neutralization Results in Support of RWM018. SRNL (2024) SRNL-TR-2023-004234, rev. 0. Interference Study Data Summary Supporting Resumed Operations of RWM018. 14 SRNS (2021) SRNS-RP-2021-05328. Annual M-Area and Met Lab HWMF Groundwater Monitoring and Corrective Action Report. Yin, Chen, Cheng, Chen, Feng, Song, and Liang (2022) Chemical Stability of Ascorbic Acid Integrated into Commercial Products: A Review on Bioactivity and Delivery Technology. Antioxidants 11(1):153. doi: 10.3390/antiox11010153. 15 8.0 Distribution william.bates@srnl.doe.gov eric.skidmore@srnl.doe.gov utopia.boynton@srnl.doe.gov michael.stone@srnl.doe.gov tyler.chavous@srnl.doe.gov boyd.wiedenman@srnl.doe.gov brandi.clark@srnl.doe.gov mary.whitehead@srnl.doe.gov marion.cofer@srnl.doe.gov morgana.whiteside@srnl.doe.gov vanessa.cofer@srnl.doe.gov holly.vermeulen@srnl.doe.gov alex.cozzi@srnl.doe.gov brandy.lewis@srnl.doe.gov c.diprete@srnl.doe.gov chris.bergren@srs.gov david.diprete@srnl.doe.gov kelsey.holcomb@srs.gov catelyn.folkert@srnl.doe.gov lance.cramer@srs.gov connie.herman@srnl.doe.gov Ashalee.Clewis@srs.gov sarah.hodges@srnl.doe.gov angelica.kelly@srs.gov charles.james@srnl.doe.gov joseph.burch@srs.gov william.jolin@srnl.doe.gov rasheed.muwwakkil@srs.gov brady.lee@srnl.doe.gov regina.marquez@srs.gov heather.capogreco@srnl.doe.gov winston.moore@srs.gov joseph.manna@srnl.doe.gov j.ross@srs.gov gregg.morgan@srnl.doe.gov manuel.terronez@srs.gov frank.pennebaker@srnl.doe.gov thelesia.oliver@srs.gov amy.ramsey@srnl.doe.gov shannan.lucero@srs.gov william.ramsey@srnl.doe.gov Records Administration (EDWS) luther.reid@srnl.doe.gov 16